<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR530.html">Part 530
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 530.13  Extralabel use from compounding of approved new animal and
                            </h3>
                            <p class="depth1"><em>(a)</em> This part applies to compounding of a product from approved  animal or human drugs by a veterinarian or a pharmacist on the order of  a veterinarian within the practice of veterinary medicine. Nothing in  this part shall be construed as permitting compounding from bulk drugs.</p><p class="depth1"><em>(b)</em> Extralabel use from compounding of approved new animal or human  drugs is permitted if:</p><p class="depth2"><em>(1)</em> All relevant portions of this part have been complied with;</p><p class="depth2"><em>(2)</em> There is no approved new animal or approved new human drug that,  when used as labeled or in conformity with criteria established in this  part, will, in the available dosage form and concentration,  appropriately treat the condition diagnosed. Compounding from a human  drug for use in food-producing animals will not be permitted if an  approved animal drug can be used for the compounding;</p><p class="depth2"><em>(3)</em> The compounding is performed by a licensed pharmacist or  veterinarian within the scope of a professional practice;</p><p class="depth2"><em>(4)</em> Adequate procedures and processes are followed that ensure the  safety and effectiveness of the compounded product;</p><p class="depth2"><em>(5)</em> The scale of the compounding operation is commensurate with the  established need for compounded products (e.g., similar to that of  comparable practices); and</p><p class="depth2"><em>(6)</em> All relevant State laws relating to the compounding of drugs for  use in animals are followed.</p><p class="depth1"><em>(c)</em> Guidance on the subject of compounding may be found in guidance  documents issued by FDA.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
